MTOR and tuberous sclerosis: TSC is an example of an etiology which, based on our understanding of underlying disease-causing mechanisms, has entered an era of more targeted treatments; examples include pre-emptive therapy with vigabatrin as well as initiation of mTOR inhibitors [119].